SensoDetect operates in the healthcare sector. The company specializes in developing medical equipment that is used to analyze how a patient's brain reacts to sound stimuli. The technology is used in psychiatry to distinguish potential mental illnesses. The product consists of electrodes that are attached to the patient's head and then analyze brain activity. The results are compared against a database for further analysis. SensoDetect was founded in 2005 and is headquartered in Lund.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Thomas Erik Frithiof Holmgren | 15,18 | 15,18 | 2025-06-26 |
| Nordnet Pensionsförsäkring | 8,96 | 8,96 | 2025-06-26 |
| Nowo Fund Management AB | 7,35 | 7,35 | 2025-07-31 |
| Karl Vilhelm Gustaf Lundin | 3,74 | 3,74 | 2025-06-26 |
| Avanza Pension | 3,48 | 3,48 | 2025-06-26 |
| Tore Robertsson | 3,14 | 3,14 | 2025-06-26 |
| Johan Möllerström med bolag | 3,05 | 3,05 | 2025-06-26 |
| Per-Anders Hedin | 2,96 | 2,96 | 2025-07-07 |
| Joachim Runesson | 2,18 | 2,18 | 2025-06-26 |
| Birgitta Möllerström | 2,09 | 2,09 | 2025-06-26 |
2025-11-11 Delårsrapport 2025-Q3
2026-02-20 Bokslutskommuniké 2025
